WASHINGTON (AP) — U.S. Supreme Court justices on Tuesday did not appear ready to limit access to the abortion pill mifepristone, in a case that could have far-reaching implications for millions of American women and for scores of drugs regulated by the Food and Drug Administration.
It’s the first abortion-related case the court has taken since a majority of the current justices struck down the constitutional right to abortion in 2022.
A group of anti-abortion doctors had asked the court to restrict access to mifepristone and to limit when in a pregnancy it could be used.
Key moments from the arguments:
College protests: Columbia University cancels main commencement
Academicians vow greater contributions
Poland hit by protests over cheap Ukrainian imports
Mainland, KMT seek common ground: Promoting exchange, opposing external interference
No, France did not deploy troops to fight with Ukraine against Russia
Senior adviser upbeat about HK's future
The northern section of Beijing Subway Line 17 will open by the end of the year
Manila move a violation of sovereignty
Hospital operator Steward Health Care files for bankruptcy protection
UK urged to refrain from meddling in HK affairs